This compound is a pharmaceutical intermediate featuring a naphthalene ring system with a diethylaminomethyl substituent and a benzoic acid moiety linked through a carbamate group. It is primarily used in the synthesis of active pharmaceutical ingredients.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 199657-47-1
Givinostat
histone deacetylase inhibitor
N-Fmoc-4-Cyclopropyl-L-phenylalanine
Protected amino acid for peptide synthesis
HCV-IN-31
HCV antiviral intermediate
(S)-1-N-Boc-piperidine-2-ethanol
pharmaceutical intermediate
4-Methylbenzene-1-sulfonic acid--(2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine (1/1)
pharmaceutical intermediate
4-[[6-(diethylaminomethyl)naphthalen-2-yl]methoxycarbonylamino]benzoic acid
NCHVNKHIEHGHEU-UHFFFAOYSA-N
CCN(CC)CC1=CC2=C(C=C1)C=C(C=C2)COC(=O)NC3=CC=C(C=C3)C(=O)O
—